Myxomatous degeneration
Myxomatous degeneration is a pathological condition where connective tissue, particularly of the heart valves, undergoes fibrous change and acquires a tumorous appearance. This condition is most commonly associated with the mitral valve, but can affect any of the heart valves.
Etiology[edit | edit source]
The exact cause of myxomatous degeneration is unknown, but it is believed to be related to genetic factors, as it is often seen in certain breeds of dogs, such as the Cavalier King Charles Spaniel. Other factors that may contribute to the development of this condition include age, sex, and certain underlying medical conditions.
Pathophysiology[edit | edit source]
In myxomatous degeneration, the connective tissue of the heart valves becomes weakened and stretched, leading to the formation of small, tumor-like nodules. These nodules can interfere with the normal functioning of the heart valves, leading to conditions such as mitral valve prolapse and mitral regurgitation.
Clinical Presentation[edit | edit source]
Patients with myxomatous degeneration may present with a variety of symptoms, depending on the severity of the condition and the specific heart valves affected. Common symptoms include shortness of breath, fatigue, palpitations, and chest pain. In severe cases, myxomatous degeneration can lead to heart failure.
Diagnosis[edit | edit source]
Diagnosis of myxomatous degeneration is typically made through a combination of physical examination, medical history, and imaging studies. Echocardiography is the most commonly used imaging technique for diagnosing this condition.
Treatment[edit | edit source]
Treatment for myxomatous degeneration depends on the severity of the condition and the specific heart valves affected. In mild cases, treatment may involve regular monitoring and lifestyle modifications. In more severe cases, surgical intervention may be necessary to repair or replace the affected heart valves.
See Also[edit | edit source]
| Myxomatous degeneration Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
